Abstract:NOD-like receptor (NLR), family pyrin domain containing 3 (NLRP3) assembles a protein complex known as the NLRP3 inflammasome upon sensing certain pathogen products or sterile danger signals. Gain-of-function mutations such as the D301N substitution in NLRP3, which cause its constitutive activation (NLRP3CA) also results in inflammasome assembly. This inflammasome processes pro–interleukin-1 β (pro–IL-1β) and pro–IL-18 into bioactive IL-1β and IL-18, respectively, and cleaves gasdermin D (GSDMD). GSDMD amino-terminal fragments form plasma membrane pores that facilitate the secretion of IL-1β and IL-18 and lead to the inflammatory cell death pyroptosis. Accordingly, GSDMD inactivation results in negligible spontaneous inflammation in various experimental models such as in Nlrp3CA/+ mice lacking GSDMD (Nlrp3CA/+;Gsdmd−/− mice). Here, we found that Nlrp3CA/+;Gsdmd−/− mice, when challenged with LPS or TNF-α, still secreted IL-1β and IL-18, indicating inflammasome activation independent of GSDMD. Accordingly, Gsdmd−/− macrophages failed to secrete IL-1β and undergo pyroptosis when briefly exposed to NLRP3 inflammasome activators but released these cytokines when persistently activated. Sustained NLRP3 inflammasome induced caspase-8/-3 and GSDME cleavage and IL-1β maturation in vitro in Gsdmd−/− macrophages. Thus, a salvage inflammatory pathway involving caspase-8/-3–GSDME was activated after NLRP3 activation when the canonical NLRP3-GSDMD signaling was blocked. Consistent with genetic data, the active metabolite of FDA-approved disulfiram CuET, which inhibited GSDMD and GSDME cleavage in macrophages, reduced the severe inflammation and tissue damage that occurred in the Nlrp3CA/+ mice. Thus, NLRP3 inflammasome activation overwhelms the protection afforded by GSDMD deficiency, rewiring signaling cascades through mechanisms that include GSDME to propagate inflammation.

Defective Endosome-Tgn Retrograde Transport Promotes NLRP3 Inflammasome Activation

Distinct changes in endosomal composition promote NLRP3 inflammasome activation

Phosphodiesterase 4B is Required for NLRP3 Inflammasome Activation by Positive Feedback with Nrf2 in the Early Phase of LPS- Induced Acute Lung Injury

Disruptions in endocytic traffic contribute to the activation of the NLRP3 inflammasome

The Roles of Endoplasmic Reticulum in NLRP3 Inflammasome Activation

Consecutive palmitoylation and phosphorylation orchestrates NLRP3 membrane trafficking and inflammasome activation

Sequential ubiquitination of NLRP3 by RNF125 and Cbl-b limits inflammasome activation and endotoxemia

NLRP3 cages revealed by full-length mouse NLRP3 structure control pathway activation

NLRP3 inflammasome activation in neutrophils directs early inflammatory response in murine peritonitis

The NLRP3 inflammasome: activation and regulation

NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis

The NLRP3 inflammasome: molecular activation and regulation to therapeutics

The Leucine-Rich Repeat (LRR) Domain of NLRP3 is Required for NLRP3 Inflammasome Activation in Macrophages

NLRP3 Inflammasome Activation Triggers Gasdermin D–independent Inflammation

Fantastic voyage: The journey of NLRP3 inflammasome activation

NLRP3 inflammasome activation, metabolic danger signals, and protein binding partners

A role for mitochondria in NLRP3 inflammasome activation

Protein kinase D at the Golgi controls NLRP3 inflammasome activation

The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation

Sensing damage by the NLRP3 inflammasome

NLRP3 Inflammasome: Activation, Regulation, and Role in Diseases